{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:25:21Z","timestamp":1787019921949,"version":"build-2736575974"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T00:00:00Z","timestamp":1635379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T00:00:00Z","timestamp":1635379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Major Research and Development Program of Hunan Province","award":["S2020GCZDYF0628"],"award-info":[{"award-number":["S2020GCZDYF0628"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 81870500"],"award-info":[{"award-number":["No. 81870500"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Hunan Provincial Clinical Medical Technology Innovation Guide Project","award":["2020SK53402"],"award-info":[{"award-number":["2020SK53402"]}]},{"DOI":"10.13039\/501100014764","name":"China International Medical Foundation","doi-asserted-by":"crossref","award":["Z-2017-24-2037"],"award-info":[{"award-number":["Z-2017-24-2037"]}],"id":[{"id":"10.13039\/501100014764","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Research Project from Blood Purification Center Branch of Chinese Hospital Association in 2021"},{"name":"Hunan Provincial Natural Science Foundation for Outstanding Youth","award":["No.2020JJ2020"],"award-info":[{"award-number":["No.2020JJ2020"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Obesity-related nephropathy (ORN) has become one of the leading causes of end-stage renal disease and has tripled over the past decade. Previous studies have demonstrated that decreased reactive oxygen species production may contribute to improving ORN by ameliorating oxidative stress injury. Here, I\u03baB kinase (IKK) was hypothesized to inactivate the deubiquitination activity of cylindromatosis (CYLD) by activating the phosphorylation of CYLD, thus promoting the ubiquitination of NF-E2-related factor 2 (Nrf2) and further aggravating oxidative stress injury of the kidney in ORN. This study was aimed to confirm this hypothesis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Haematoxylin and eosin (HE), periodic acid-Schiff (PAS) and Oil Red O staining were performed to assess histopathology. Dihydroethidium (DHE) staining and MDA, SOD, CAT, and GSH-PX assessments were performed to measure reactive oxygen species (ROS) production. Immunohistochemical (IHC) staining, qRT\u2013PCR and\/or western blotting were performed to assess the expression of related genes. JC-1 assays were used to measure the mitochondrial membrane potential (\u0394\u03a8m) of treated HK-2 cells. Co-immunoprecipitation experiments (Co-IP) were used to analyse the interaction between CYLD and Nrf2 in ORN.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>ORN in vivo and in vitro models were successfully constructed, and oxidative stress injury was detected in the model tissues and cells. Compared with the control groups, the phosphorylation level of CYLD increased while Nrf2 levels decreased in ORN model cells. An IKK inhibitor reduced lipid deposition, ROS production, CYLD phosphorylation levels and \u0394\u03a8m in vitro, which were reversed by knockdown of CYLD. Nrf2 directly bound to CYLD and was ubiquitinated in ORN cells. The proteasome inhibitor MG132 activated the Nrf2\/ARE signalling pathway, thereby reversing the promoting effect of CYLD knockdown on oxidative stress.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>IKK inactivates the deubiquitination activity of CYLD by activating the phosphorylation of CYLD, thus promoting the ubiquitination of Nrf2 and further aggravating oxidative stress injury of the kidney in ORN. This observation provided a feasible basis for the treatment of kidney damage caused by ORN.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s10020-021-00398-w","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T15:42:44Z","timestamp":1635435764000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["I\u03baB kinase promotes Nrf2 ubiquitination and degradation by phosphorylating cylindromatosis, aggravating oxidative stress injury in obesity-related nephropathy"],"prefix":"10.1186","volume":"27","author":[{"given":"Yin-Yin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ting","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ya","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6759-2069","authenticated-orcid":false,"given":"Li-Yu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,28]]},"reference":[{"key":"398_CR1","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.mehy.2014.11.013","volume":"84","author":"CC Abreu","year":"2015","unstructured":"Abreu CC, Cardozo LF, Mafra D. Could physical exercises modulate Nrf2-Keap1 pathway in chronic kidney disease? Med Hypotheses. 2015;84:44\u20136.","journal-title":"Med Hypotheses"},{"key":"398_CR2","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1042\/CS20150436","volume":"129","author":"O Al-Sawaf","year":"2015","unstructured":"Al-Sawaf O, et al. Nrf2 in health and disease: current and future clinical implications. Clin Sci (lond). 2015;129:989\u201399.","journal-title":"Clin Sci (lond)"},{"key":"398_CR3","doi-asserted-by":"publisher","first-page":"F941","DOI":"10.1152\/ajprenal.00203.2019","volume":"317","author":"A Andres-Hernando","year":"2019","unstructured":"Andres-Hernando A, et al. Obesity causes renal mitochondrial dysfunction and energy imbalance and accelerates chronic kidney disease in mice. Am J Physiol Renal Physiol. 2019;317:F941\u20138.","journal-title":"Am J Physiol Renal Physiol"},{"key":"398_CR4","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.bbamcr.2018.02.010","volume":"1865","author":"I Bellezza","year":"2018","unstructured":"Bellezza I, Giambanco I, Minelli A, Donato R. Nrf2-Keap1 signaling in oxidative and reductive stress. Biochim Biophys Acta Mol Cell Res. 2018;1865:721\u201333.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"398_CR5","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nrneph.2016.75","volume":"12","author":"VD D'Agati","year":"2016","unstructured":"D\u2019Agati VD, et al. Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis. Nat Rev Nephrol. 2016;12:453\u201371.","journal-title":"Nat Rev Nephrol"},{"key":"398_CR6","doi-asserted-by":"publisher","first-page":"R803","DOI":"10.1152\/ajpregu.00187.2009","volume":"297","author":"JM do Carmo","year":"2009","unstructured":"do Carmo JM, et al. Impact of obesity on renal structure and function in the presence and absence of hypertension: evidence from melanocortin-4 receptor-deficient mice. Am J Physiol Regul Integr Comp Physiol. 2009;297:R803-812.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"398_CR7","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1093\/cvr\/cvp107","volume":"83","author":"H Dreger","year":"2009","unstructured":"Dreger H, et al. Nrf2-dependent upregulation of antioxidative enzymes: a novel pathway for proteasome inhibitor-mediated cardioprotection. Cardiovasc Res. 2009;83:354\u201361.","journal-title":"Cardiovasc Res"},{"key":"398_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2011.05.006","volume":"1397","author":"W Duan","year":"2011","unstructured":"Duan W, Guo Y, Jiang H, Yu X, Li C. MG132 enhances neurite outgrowth in neurons overexpressing mutant TAR DNA-binding protein-43 via increase of HO-1. Brain Res. 2011;1397:1\u20139.","journal-title":"Brain Res"},{"key":"398_CR9","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1590\/2359-3997000000188","volume":"60","author":"SM Fernandes","year":"2016","unstructured":"Fernandes SM, Cordeiro PM, Watanabe M, Fonseca CD, Vattimo MF. The role of oxidative stress in streptozotocin-induced diabetic nephropathy in rats. Arch Endocrinol Metab. 2016;60:443\u20139.","journal-title":"Arch Endocrinol Metab"},{"key":"398_CR10","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.freeradbiomed.2017.12.013","volume":"115","author":"W Gong","year":"2018","unstructured":"Gong W, et al. CKIP-1 affects the polyubiquitination of Nrf2 and Keap1 via mediating Smurf1 to resist HG-induced renal fibrosis in GMCs and diabetic mice kidneys. Free Radic Biol Med. 2018;115:338\u201350.","journal-title":"Free Radic Biol Med"},{"key":"398_CR11","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1210\/en.2010-1038","volume":"152","author":"J Habibi","year":"2011","unstructured":"Habibi J, et al. Nebivolol attenuates redox-sensitive glomerular and tubular mediated proteinuria in obese rats. Endocrinology. 2011;152:659\u201368.","journal-title":"Endocrinology"},{"key":"398_CR12","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1161\/CIRCRESAHA.116.305697","volume":"116","author":"JE Hall","year":"2015","unstructured":"Hall JE, do Carmo JM, da Silva AA, Wang Z, Hall ME. Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms. Circ Res. 2015;116:991\u20131006.","journal-title":"Circ Res"},{"key":"398_CR13","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1101\/gad.1228704","volume":"18","author":"MS Hayden","year":"2004","unstructured":"Hayden MS, Ghosh S. Signaling to NF-kappaB. Genes Dev. 2004;18:2195\u2013224.","journal-title":"Genes Dev"},{"key":"398_CR14","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev.biochem.67.1.425","volume":"67","author":"A Hershko","year":"1998","unstructured":"Hershko A, Ciechanover A. The ubiquitin system. Annu Rev Biochem. 1998;67:425\u201379.","journal-title":"Annu Rev Biochem"},{"key":"398_CR15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.7326\/0003-4819-144-1-200601030-00006","volume":"144","author":"CY Hsu","year":"2006","unstructured":"Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS. Body mass index and risk for end-stage renal disease. Ann Intern Med. 2006;144:21\u20138.","journal-title":"Ann Intern Med"},{"key":"398_CR16","doi-asserted-by":"publisher","first-page":"10994","DOI":"10.1038\/s41598-020-67910-w","volume":"10","author":"R Hu","year":"2020","unstructured":"Hu R, et al. Spectrum of biopsy proven renal diseases in Central China: a 10-year retrospective study based on 34,630 cases. Sci Rep. 2020;10:10994.","journal-title":"Sci Rep"},{"key":"398_CR17","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.molcel.2009.04.031","volume":"34","author":"JE Hutti","year":"2009","unstructured":"Hutti JE, et al. Phosphorylation of the tumor suppressor CYLD by the breast cancer oncogene IKKepsilon promotes cell transformation. Mol Cell. 2009;34:461\u201372.","journal-title":"Mol Cell"},{"key":"398_CR18","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.mam.2011.10.006","volume":"32","author":"BM Hybertson","year":"2011","unstructured":"Hybertson BM, Gao B, Bose SK, McCord JM. Oxidative stress in health and disease: the therapeutic potential of Nrf2 activation. Mol Aspects Med. 2011;32:234\u201346.","journal-title":"Mol Aspects Med"},{"key":"398_CR19","doi-asserted-by":"publisher","first-page":"F125","DOI":"10.1152\/ajprenal.00248.2009","volume":"298","author":"EA Jaimes","year":"2010","unstructured":"Jaimes EA, Hua P, Tian RX, Raij L. Human glomerular endothelium: interplay among glucose, free fatty acids, angiotensin II, and oxidative stress. Am J Physiol Renal Physiol. 2010;298:F125-132.","journal-title":"Am J Physiol Renal Physiol"},{"key":"398_CR20","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1046\/j.1523-1755.2001.0590041498.x","volume":"59","author":"N Kambham","year":"2001","unstructured":"Kambham N, Markowitz GS, Valeri AM, Lin J, D\u2019Agati VD. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int. 2001;59:1498\u2013509.","journal-title":"Kidney Int"},{"key":"398_CR21","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12933-017-0604-9","volume":"16","author":"BS Karam","year":"2017","unstructured":"Karam BS, Chavez-Moreno A, Koh W, Akar JG, Akar FG. Oxidative stress and inflammation as central mediators of atrial fibrillation in obesity and diabetes. Cardiovasc Diabetol. 2017;16:120.","journal-title":"Cardiovasc Diabetol"},{"key":"398_CR22","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s10557-014-6530-0","volume":"28","author":"MAH Khan","year":"2014","unstructured":"Khan MAH, Neckar J, Cummens B, Wahl GM, Imig JD. Azilsartan decreases renal and cardiovascular injury in the spontaneously hypertensive obese rat. Cardiovasc Drugs Ther. 2014;28:313\u201322.","journal-title":"Cardiovasc Drugs Ther"},{"key":"398_CR23","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/nature01802","volume":"424","author":"A Kovalenko","year":"2003","unstructured":"Kovalenko A, et al. The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination. Nature. 2003;424:801\u20135.","journal-title":"Nature"},{"key":"398_CR24","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1146\/annurev-pharmtox-011112-140320","volume":"53","author":"Q Ma","year":"2013","unstructured":"Ma Q. Role of nrf2 in oxidative stress and toxicity. Annu Rev Pharmacol Toxicol. 2013;53:401\u201326.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"398_CR25","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.3390\/ijerph15061173","volume":"15","author":"C Park","year":"2018","unstructured":"Park C, et al. Activation of the Nrf2\/HO-1 signaling pathway contributes to the protective effects of sargassum serratifolium extract against oxidative stress-induced DNA damage and apoptosis in SW1353 human chondrocytes. Int J Environ Res Public Health. 2018;15:1173.","journal-title":"Int J Environ Res Public Health"},{"key":"398_CR26","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/TP.0000000000002480","volume":"103","author":"I Pierantonelli","year":"2019","unstructured":"Pierantonelli I, Svegliati-Baroni G. Nonalcoholic fatty liver disease: basic pathogenetic mechanisms in the progression from NAFLD to NASH. Transplantation. 2019;103:e1\u201313.","journal-title":"Transplantation"},{"key":"398_CR27","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.lfs.2016.02.002","volume":"148","author":"V Rani","year":"2016","unstructured":"Rani V, Deep G, Singh RK, Palle K, Yadav UC. Oxidative stress and metabolic disorders: pathogenesis and therapeutic strategies. Life Sci. 2016;148:183\u201393.","journal-title":"Life Sci"},{"key":"398_CR28","doi-asserted-by":"publisher","first-page":"3886","DOI":"10.1128\/MCB.25.10.3886-3895.2005","volume":"25","author":"W Reiley","year":"2005","unstructured":"Reiley W, Zhang M, Wu X, Granger E, Sun SC. Regulation of the deubiquitinating enzyme CYLD by IkappaB kinase gamma-dependent phosphorylation. Mol Cell Biol. 2005;25:3886\u201395.","journal-title":"Mol Cell Biol"},{"key":"398_CR29","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.thromres.2008.01.011","volume":"122","author":"SK Sahni","year":"2008","unstructured":"Sahni SK, Rydkina E, Sahni A. The proteasome inhibitor MG132 induces nuclear translocation of erythroid transcription factor Nrf2 and cyclooxygenase-2 expression in human vascular endothelial cells. Thromb Res. 2008;122:820\u20135.","journal-title":"Thromb Res"},{"key":"398_CR30","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1038\/sj.ijo.0803009","volume":"29","author":"A Saiki","year":"2005","unstructured":"Saiki A, et al. Effect of weight loss using formula diet on renal function in obese patients with diabetic nephropathy. Int J Obes (lond). 2005;29:1115\u201320.","journal-title":"Int J Obes (lond)"},{"key":"398_CR31","doi-asserted-by":"publisher","first-page":"F589","DOI":"10.1152\/ajprenal.00392.2019","volume":"318","author":"Y Shi","year":"2020","unstructured":"Shi Y, et al. Downregulation of PTEN promotes podocyte endocytosis of lipids aggravating obesity-related glomerulopathy. Am J Physiol Renal Physiol. 2020;318:F589\u201399.","journal-title":"Am J Physiol Renal Physiol"},{"key":"398_CR32","doi-asserted-by":"publisher","first-page":"7991","DOI":"10.1007\/s11033-020-05732-9","volume":"47","author":"X Su","year":"2020","unstructured":"Su X, Peng D. Emerging functions of adipokines in linking the development of obesity and cardiovascular diseases. Mol Biol Rep. 2020;47:7991.","journal-title":"Mol Biol Rep"},{"key":"398_CR33","doi-asserted-by":"publisher","first-page":"608397","DOI":"10.1155\/2012\/608397","volume":"2012","author":"J Tang","year":"2012","unstructured":"Tang J, Yan H, Zhuang S. Inflammation and oxidative stress in obesity-related glomerulopathy. Int J Nephrol. 2012;2012:608397.","journal-title":"Int J Nephrol"},{"key":"398_CR34","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.kint.2016.07.045","volume":"90","author":"C Tang","year":"2016","unstructured":"Tang C, Cai J, Dong Z. Mitochondrial dysfunction in obesity-related kidney disease: a novel therapeutic target. Kidney Int. 2016;90:930\u20133.","journal-title":"Kidney Int"},{"key":"398_CR35","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/nature01803","volume":"424","author":"E Trompouki","year":"2003","unstructured":"Trompouki E, et al. CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members. Nature. 2003;424:793\u20136.","journal-title":"Nature"},{"key":"398_CR36","doi-asserted-by":"publisher","first-page":"14960","DOI":"10.1073\/pnas.93.25.14960","volume":"93","author":"R Venugopal","year":"1996","unstructured":"Venugopal R, Jaiswal AK. Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene. Proc Natl Acad Sci U S A. 1996;93:14960\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"398_CR37","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/sj.ijo.0803177","volume":"30","author":"HK Vincent","year":"2006","unstructured":"Vincent HK, Taylor AG. Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans. Int J Obes (lond). 2006;30:400\u201318.","journal-title":"Int J Obes (lond)"},{"key":"398_CR38","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1093\/epirev\/mxm007","volume":"29","author":"Y Wang","year":"2007","unstructured":"Wang Y, Beydoun MA. The obesity epidemic in the United States\u2013gender, age, socioeconomic, racial\/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol Rev. 2007;29:6\u201328.","journal-title":"Epidemiol Rev"},{"key":"398_CR39","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.yjmcc.2015.04.012","volume":"84","author":"H Wang","year":"2015","unstructured":"Wang H, et al. Deubiquitinating enzyme CYLD mediates pressure overload-induced cardiac maladaptive remodeling and dysfunction via downregulating Nrf2. J Mol Cell Cardiol. 2015;84:143\u201353.","journal-title":"J Mol Cell Cardiol"},{"key":"398_CR40","first-page":"74","volume":"44","author":"T Wang","year":"2019","unstructured":"Wang T, et al. Role of Nrf2\/HO-1 signal axis in the mechanisms for oxidative stress-relevant diseases. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2019;44:74\u201380.","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"398_CR41","doi-asserted-by":"publisher","first-page":"F2","DOI":"10.1093\/eurheartj\/suw030","volume":"18","author":"C Weiwei","year":"2016","unstructured":"Weiwei C, et al. Outline of the report on cardiovascular diseases in China, 2014. Eur Heart J Suppl. 2016;18:F2\u201311.","journal-title":"Eur Heart J Suppl"},{"key":"398_CR42","doi-asserted-by":"publisher","first-page":"e3075","DOI":"10.1002\/dmrr.3075","volume":"35","author":"Y Xia","year":"2019","unstructured":"Xia Y, Xie Z, Huang G, Zhou Z. Incidence and trend of type 1 diabetes and the underlying environmental determinants. Diabetes Metab Res Rev. 2019;35:e3075.","journal-title":"Diabetes Metab Res Rev"},{"key":"398_CR43","doi-asserted-by":"publisher","first-page":"465","DOI":"10.3109\/02656736.2016.1155762","volume":"32","author":"L Xu","year":"2016","unstructured":"Xu L, et al. Punicalagin induces Nrf2 translocation and HO-1 expression via PI3K\/Akt, protecting rat intestinal epithelial cells from oxidative stress. Int J Hyperthermia. 2016;32:465\u201373.","journal-title":"Int J Hyperthermia"},{"key":"398_CR44","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1007\/s11684-017-0570-3","volume":"11","author":"T Xu","year":"2017","unstructured":"Xu T, Sheng Z, Yao L. Obesity-related glomerulopathy: pathogenesis, pathologic, clinical characteristics and treatment. Front Med. 2017;11:340\u20138.","journal-title":"Front Med"},{"key":"398_CR45","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41419-020-2294-6","volume":"11","author":"X Xu","year":"2020","unstructured":"Xu X, et al. Reversal of CYLD phosphorylation as a novel therapeutic approach for adult T-cell leukemia\/lymphoma (ATLL). Cell Death Dis. 2020;11:94.","journal-title":"Cell Death Dis"},{"key":"398_CR46","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1159\/000507784","volume":"45","author":"S Yang","year":"2020","unstructured":"Yang S, Cao C, Deng T, Zhou Z. Obesity-related glomerulopathy: a latent change in obesity requiring more attention. Kidney Blood Press Res. 2020;45:510\u201322.","journal-title":"Kidney Blood Press Res"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-021-00398-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-021-00398-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-021-00398-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T16:04:22Z","timestamp":1635437062000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.1186\/s10020-021-00398-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,28]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["398"],"URL":"https:\/\/doi.org\/10.1186\/s10020-021-00398-w","relation":{},"ISSN":["1076-1551","1528-3658"],"issn-type":[{"value":"1076-1551","type":"print"},{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,28]]},"assertion":[{"value":"31 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments were performed according to protocols from The Second Xiangya Hospital of Central South University and approved by The Second Xiangya Hospital of Central South University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no commercial or other associations that might pose a conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"137"}}